世界の炎症性皮膚疾患薬市場：市場規模・現状・予測

• 英文タイトル：Global Inflammatory Skin Diseases Drugs Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7364 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当資料は、炎症性皮膚疾患薬のグローバル市場について調査・分析したレポートで、種類別（レチノイド、コルチコステロイド、カルシニューリン阻害剤、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・炎症性皮膚疾患薬の世界市場規模 ・主要企業別市場シェア ・炎症性皮膚疾患薬の世界市場規模：種類別（レチノイド、コルチコステロイド、カルシニューリン阻害剤、その他） ・炎症性皮膚疾患薬の世界市場規模：用途別（病院薬局、小売薬局、オンライン薬局） ・炎症性皮膚疾患薬のアメリカ市場規模（種類別、用途別） ・炎症性皮膚疾患薬のヨーロッパ市場規模（種類別、用途別） ・炎症性皮膚疾患薬の中国市場規模（種類別、用途別） ・炎症性皮膚疾患薬の日本市場規模（種類別、用途別） ・炎症性皮膚疾患薬の東南アジア市場規模（種類別、用途別） ・炎症性皮膚疾患薬のインド市場規模（種類別、用途別） ・炎症性皮膚疾患薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・炎症性皮膚疾患薬の世界市場予測（2019年-2025年） ・炎症性皮膚疾患薬の地域別市場予測（2019年-2025年） ...

In 2018, the global Inflammatory Skin Diseases Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Inflammatory Skin Diseases Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Inflammatory Skin Diseases Drugs development in United States, Europe and China.

The key players covered in this study
Pfizer
Merck
AbbVie
Novartis
Boehringer Ingelheim
Amgen
Eli Lilly
…

Market segment by Type, the product can be split into
Retinoids
Corticosteroids
Calcineurin Inhibitors
Others

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Inflammatory Skin Diseases Drugs status, future forecast, growth opportunity, key market and key players.
To present the Inflammatory Skin Diseases Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Inflammatory Skin Diseases Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Inflammatory Skin Diseases Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Retinoids
1.4.3 Corticosteroids
1.4.4 Calcineurin Inhibitors
1.4.5 Others
1.5 Market by Application
1.5.1 Global Inflammatory Skin Diseases Drugs Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Inflammatory Skin Diseases Drugs Market Size
2.2 Inflammatory Skin Diseases Drugs Growth Trends by Regions
2.2.1 Inflammatory Skin Diseases Drugs Market Size by Regions (2014-2025)
2.2.2 Inflammatory Skin Diseases Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Inflammatory Skin Diseases Drugs Market Size by Manufacturers
3.1.1 Global Inflammatory Skin Diseases Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Inflammatory Skin Diseases Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Inflammatory Skin Diseases Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Inflammatory Skin Diseases Drugs Key Players Head office and Area Served
3.3 Key Players Inflammatory Skin Diseases Drugs Product/Solution/Service
3.4 Date of Enter into Inflammatory Skin Diseases Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Inflammatory Skin Diseases Drugs Market Size by Type (2014-2019)
4.2 Global Inflammatory Skin Diseases Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Inflammatory Skin Diseases Drugs Market Size (2014-2019)
5.2 Inflammatory Skin Diseases Drugs Key Players in United States
5.3 United States Inflammatory Skin Diseases Drugs Market Size by Type
5.4 United States Inflammatory Skin Diseases Drugs Market Size by Application

6 Europe
6.1 Europe Inflammatory Skin Diseases Drugs Market Size (2014-2019)
6.2 Inflammatory Skin Diseases Drugs Key Players in Europe
6.3 Europe Inflammatory Skin Diseases Drugs Market Size by Type
6.4 Europe Inflammatory Skin Diseases Drugs Market Size by Application

7 China
7.1 China Inflammatory Skin Diseases Drugs Market Size (2014-2019)
7.2 Inflammatory Skin Diseases Drugs Key Players in China
7.3 China Inflammatory Skin Diseases Drugs Market Size by Type
7.4 China Inflammatory Skin Diseases Drugs Market Size by Application

8 Japan
8.1 Japan Inflammatory Skin Diseases Drugs Market Size (2014-2019)
8.2 Inflammatory Skin Diseases Drugs Key Players in Japan
8.3 Japan Inflammatory Skin Diseases Drugs Market Size by Type
8.4 Japan Inflammatory Skin Diseases Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Inflammatory Skin Diseases Drugs Market Size (2014-2019)
9.2 Inflammatory Skin Diseases Drugs Key Players in Southeast Asia
9.3 Southeast Asia Inflammatory Skin Diseases Drugs Market Size by Type
9.4 Southeast Asia Inflammatory Skin Diseases Drugs Market Size by Application

10 India
10.1 India Inflammatory Skin Diseases Drugs Market Size (2014-2019)
10.2 Inflammatory Skin Diseases Drugs Key Players in India
10.3 India Inflammatory Skin Diseases Drugs Market Size by Type
10.4 India Inflammatory Skin Diseases Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Inflammatory Skin Diseases Drugs Market Size (2014-2019)
11.2 Inflammatory Skin Diseases Drugs Key Players in Central & South America
11.3 Central & South America Inflammatory Skin Diseases Drugs Market Size by Type
11.4 Central & South America Inflammatory Skin Diseases Drugs Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Inflammatory Skin Diseases Drugs Introduction
12.1.4 Pfizer Revenue in Inflammatory Skin Diseases Drugs Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Merck
12.2.1 Merck Company Details
12.2.2 Company Description and Business Overview
12.2.3 Inflammatory Skin Diseases Drugs Introduction
12.2.4 Merck Revenue in Inflammatory Skin Diseases Drugs Business (2014-2019)
12.2.5 Merck Recent Development
12.3 AbbVie
12.3.1 AbbVie Company Details
12.3.2 Company Description and Business Overview
12.3.3 Inflammatory Skin Diseases Drugs Introduction
12.3.4 AbbVie Revenue in Inflammatory Skin Diseases Drugs Business (2014-2019)
12.3.5 AbbVie Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Inflammatory Skin Diseases Drugs Introduction
12.4.4 Novartis Revenue in Inflammatory Skin Diseases Drugs Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Boehringer Ingelheim
12.5.1 Boehringer Ingelheim Company Details
12.5.2 Company Description and Business Overview
12.5.3 Inflammatory Skin Diseases Drugs Introduction
12.5.4 Boehringer Ingelheim Revenue in Inflammatory Skin Diseases Drugs Business (2014-2019)
12.5.5 Boehringer Ingelheim Recent Development
12.6 Amgen
12.6.1 Amgen Company Details
12.6.2 Company Description and Business Overview
12.6.3 Inflammatory Skin Diseases Drugs Introduction
12.6.4 Amgen Revenue in Inflammatory Skin Diseases Drugs Business (2014-2019)
12.6.5 Amgen Recent Development
12.7 Eli Lilly
12.7.1 Eli Lilly Company Details
12.7.2 Company Description and Business Overview
12.7.3 Inflammatory Skin Diseases Drugs Introduction
12.7.4 Eli Lilly Revenue in Inflammatory Skin Diseases Drugs Business (2014-2019)
12.7.5 Eli Lilly Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Inflammatory Skin Diseases Drugs Key Market Segments
Table Key Players Inflammatory Skin Diseases Drugs Covered
Table Global Inflammatory Skin Diseases Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Inflammatory Skin Diseases Drugs Market Size Market Share by Type 2014-2025
Figure Retinoids Figures
Table Key Players of Retinoids
Figure Corticosteroids Figures
Table Key Players of Corticosteroids
Figure Calcineurin Inhibitors Figures
Table Key Players of Calcineurin Inhibitors
Figure Others Figures
Table Key Players of Others
Table Global Inflammatory Skin Diseases Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Inflammatory Skin Diseases Drugs Report Years Considered
Table Global Inflammatory Skin Diseases Drugs Market Size 2014-2025 (Million US$)
Figure Global Inflammatory Skin Diseases Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Inflammatory Skin Diseases Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Inflammatory Skin Diseases Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Inflammatory Skin Diseases Drugs Market Share by Regions 2014-2019
Figure Global Inflammatory Skin Diseases Drugs Market Share by Regions 2014-2019
Figure Global Inflammatory Skin Diseases Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Inflammatory Skin Diseases Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Inflammatory Skin Diseases Drugs Market Share by Manufacturers (2014-2019)
Figure Global Inflammatory Skin Diseases Drugs Market Share by Manufacturers in 2018
Table Global Inflammatory Skin Diseases Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Inflammatory Skin Diseases Drugs Product/Solution/Service
Table Date of Enter into Inflammatory Skin Diseases Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Inflammatory Skin Diseases Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Inflammatory Skin Diseases Drugs Market Size Share by Type (2014-2019)
Figure Global Inflammatory Skin Diseases Drugs Market Size Market Share by Type (2014-2019)
Table Global Inflammatory Skin Diseases Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Inflammatory Skin Diseases Drugs Market Size Share by Application (2014-2019)
Figure Global Inflammatory Skin Diseases Drugs Market Size Market Share by Application (2014-2019)
Figure Global Inflammatory Skin Diseases Drugs Revenue Market Share by Application in 2018
Figure United States Inflammatory Skin Diseases Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Inflammatory Skin Diseases Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Inflammatory Skin Diseases Drugs Market Share (2018-2019)
Table United States Inflammatory Skin Diseases Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Inflammatory Skin Diseases Drugs Market Share by Type (2014-2019)
Table United States Inflammatory Skin Diseases Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Inflammatory Skin Diseases Drugs Market Share by Application (2014-2019)
Figure Europe Inflammatory Skin Diseases Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Inflammatory Skin Diseases Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Inflammatory Skin Diseases Drugs Market Share (2018-2019)
Table Europe Inflammatory Skin Diseases Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Inflammatory Skin Diseases Drugs Market Share by Type (2014-2019)
Table Europe Inflammatory Skin Diseases Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Inflammatory Skin Diseases Drugs Market Share by Application (2014-2019)
Figure China Inflammatory Skin Diseases Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Inflammatory Skin Diseases Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Inflammatory Skin Diseases Drugs Market Share (2018-2019)
Table China Inflammatory Skin Diseases Drugs Market Size by Type (2014-20189) (Million US$)
Table China Inflammatory Skin Diseases Drugs Market Share by Type (2014-2019)
Table China Inflammatory Skin Diseases Drugs Market Size by Application (2014-2019) (Million US$)
Table China Inflammatory Skin Diseases Drugs Market Share by Application (2014-2019)
Figure Japan Inflammatory Skin Diseases Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Inflammatory Skin Diseases Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Inflammatory Skin Diseases Drugs Market Share (2018-2019)
Table Japan Inflammatory Skin Diseases Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Inflammatory Skin Diseases Drugs Market Share by Type (2014-2019)
Table Japan Inflammatory Skin Diseases Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Inflammatory Skin Diseases Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Inflammatory Skin Diseases Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Inflammatory Skin Diseases Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Inflammatory Skin Diseases Drugs Market Share (2018-2019)
Table Southeast Asia Inflammatory Skin Diseases Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Inflammatory Skin Diseases Drugs Market Share by Type (2014-2019)
Table Southeast Asia Inflammatory Skin Diseases Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Inflammatory Skin Diseases Drugs Market Share by Application (2014-2019)
Figure India Inflammatory Skin Diseases Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Inflammatory Skin Diseases Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Inflammatory Skin Diseases Drugs Market Share (2018-2019)
Table India Inflammatory Skin Diseases Drugs Market Size by Type (2014-2019) (Million US$)
Table India Inflammatory Skin Diseases Drugs Market Share by Type (2014-2019)
Table India Inflammatory Skin Diseases Drugs Market Size by Application (2014-2019) (Million US$)
Table India Inflammatory Skin Diseases Drugs Market Share by Application (2014-2019)
Figure Central & South America Inflammatory Skin Diseases Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Inflammatory Skin Diseases Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Inflammatory Skin Diseases Drugs Market Share (2018-2019)
Table Central & South America Inflammatory Skin Diseases Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Inflammatory Skin Diseases Drugs Market Share by Type (2014-2019)
Table Central & South America Inflammatory Skin Diseases Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Inflammatory Skin Diseases Drugs Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Inflammatory Skin Diseases Drugs Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Merck Company Details
Table Merck Revenue in Inflammatory Skin Diseases Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2014-2019)
Table Merck Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Inflammatory Skin Diseases Drugs Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2014-2019)
Table AbbVie Recent Development
Table Novartis Company Details
Table Novartis Revenue in Inflammatory Skin Diseases Drugs Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2014-2019)
Table Novartis Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Inflammatory Skin Diseases Drugs Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Amgen Company Details
Table Amgen Revenue in Inflammatory Skin Diseases Drugs Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2014-2019)
Table Amgen Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Inflammatory Skin Diseases Drugs Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2014-2019)
Table Eli Lilly Recent Development
Table Global Inflammatory Skin Diseases Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Inflammatory Skin Diseases Drugs Market Size Share by Regions (2019-2025)
Figure Global Inflammatory Skin Diseases Drugs Market Size Share by Regions in 2025
Figure United States Inflammatory Skin Diseases Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Inflammatory Skin Diseases Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Inflammatory Skin Diseases Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Inflammatory Skin Diseases Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Inflammatory Skin Diseases Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Inflammatory Skin Diseases Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Inflammatory Skin Diseases Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Inflammatory Skin Diseases Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Inflammatory Skin Diseases Drugs Market Size by Product (2019-2025)
Figure Global Inflammatory Skin Diseases Drugs Market Size by Product in 2025
Table Global Inflammatory Skin Diseases Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Inflammatory Skin Diseases Drugs Market Size by Application (2019-2025)
Figure Global Inflammatory Skin Diseases Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---